methionine sulfoximine has been researched along with Lung Neoplasms in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (42.31) | 18.7374 |
1990's | 14 (53.85) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (3.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castegna, A; De Tullio, G; Ghesquière, B; Guarini, A; Hooper, DC; Lamers, WH; Martín-Pérez, R; Mazzone, M; McVicar, DW; Menga, A; Palmieri, EM; Quinto, A; Riera-Domingo, C | 1 |
Astor, M; Biaglow, JE; Clark, EP; Epp, ER; Varnes, ME | 1 |
Biaglow, JE; Hall, EJ; Roizin-Towle, L; Varnes, ME | 1 |
Biaglow, JE; McPherson, S; Mitchell, JB; Russo, A | 1 |
Biaglow, JE; Clark, EP; Epp, ER; Varnes, ME | 1 |
Burt, ME; Hochwald, SN; Port, JL; Wang, HY | 1 |
Hwang, J; Lai, SL; Perng, RP; Whang-Peng, J | 1 |
Bagrij, T; Broxterman, HJ; Scheper, RJ; Twentyman, PR; Versantvoort, CH | 1 |
Baas, F; Beijnen, J; Borst, P; Dekker, H; Lankelma, J; Oude Elferink, RP; Paulusma, C; van Tellingen, O; Zaman, GJ | 1 |
Kang, YJ | 3 |
Alena, F; Gili, A; Iwashina, T; Jimbow, K | 1 |
Lafleur, MV; Lankelma, J; Mans, DR; Pinedo, HM; Retèl, J; Schuurhuis, GJ; Treskes, M | 1 |
de Vries, EG; Meijer, C; Mulder, NH; Peters, WH; Timmer-Bosscha, H | 1 |
Emery, D; Enger, MD; Kang, YJ | 1 |
al-Kabban, M; Reglinski, J; Stewart, MJ; Watson, ID | 1 |
Enger, MD; Kang, YJ | 3 |
de Vries, EG; Hospers, GA; Meijer, C; Mulder, NH; Uges, DR | 1 |
DeGraff, W; Friedman, N; Mitchell, JB; Russo, A | 1 |
Clapper, JA; Enger, MD; Kang, YJ | 1 |
Konings, AW; Lemstra, W; Malingré, TM; Woerdenbag, HJ | 1 |
Abe, M; Komuro, C; Nishidai, T; Ono, K; Shibamoto, Y; Shrieve, DC; Takahashi, M; Tsutsui, K | 1 |
Brodie, AE; Reed, DJ | 1 |
26 other study(ies) available for methionine sulfoximine and Lung Neoplasms
Article | Year |
---|---|
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Movement; Endothelial Cells; Enzyme Inhibitors; Glucose; Glutamate-Ammonia Ligase; Glutamine; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Injections, Subcutaneous; Interleukin-10; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Macrophages; Methionine Sulfoximine; Mice; Mice, Knockout; Monocytes; Neovascularization, Pathologic; Primary Cell Culture; Succinic Acid; T-Lymphocytes, Cytotoxic | 2017 |
Factors involved in depletion of glutathione from A549 human lung carcinoma cells: implications for radiotherapy.
Topics: Buthionine Sulfoximine; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Glutathione; Humans; Lung Neoplasms; Maleates; Methionine Sulfoximine; Radiation-Sensitizing Agents; Time Factors | 1984 |
Depletion of intracellular GSH and NPSH by buthionine sulfoximine and diethyl maleate: factors that influence enhancement of aerobic radiation response.
Topics: Aerobiosis; Buthionine Sulfoximine; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Glutathione; Humans; Lung Neoplasms; Maleates; Methionine Sulfoximine; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Time Factors | 1984 |
Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Topics: Animals; Buthionine Sulfoximine; Carcinoma; Cell Line; Cells, Cultured; Cricetinae; Dose-Response Relationship, Radiation; Glutathione; Humans; Hypoxia; Lung; Lung Neoplasms; Maleates; Methionine Sulfoximine; Oxygen Consumption; Radiation-Sensitizing Agents; Time Factors | 1983 |
The role of thiols in cellular response to radiation and drugs.
Topics: Animals; Azo Compounds; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Chemical Phenomena; Chemistry; Cricetinae; Diamide; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Glutathione; Humans; Lung Neoplasms; Maleates; Methionine Sulfoximine; Ovary; Oxygen; Radiation-Sensitizing Agents; Sulfhydryl Compounds | 1983 |
Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin.
Topics: Animals; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Chemotherapy, Cancer, Regional Perfusion; Doxorubicin; Drug Synergism; Glutathione; Hydroxyethyl Starch Derivatives; Liver; Lung Neoplasms; Male; Methionine Sulfoximine; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1995 |
Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA Repair; DNA, Neoplasm; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Glutathione; Glutathione Transferase; Humans; Intracellular Fluid; Lung Neoplasms; Methionine Sulfoximine; Pentoxifylline; Tumor Cells, Cultured | 1995 |
Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
Topics: Biological Transport; Buthionine Sulfoximine; Daunorubicin; Drug Resistance, Multiple; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Rhodamine 123; Rhodamines; RNA, Messenger; Tumor Cells, Cultured | 1995 |
Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Arsenites; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Buthionine Sulfoximine; Carcinoma, Non-Small-Cell Lung; Cell Division; Cysteine; Drug Resistance, Multiple; Glutathione; Humans; Kinetics; Lung Neoplasms; Methionine Sulfoximine; Multidrug Resistance-Associated Proteins; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1995 |
Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
Topics: Analysis of Variance; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Division; Cell Line; Chromatography, High Pressure Liquid; DNA Replication; Glutamates; Glutathione; Humans; Kinetics; Lung Neoplasms; Methionine Sulfoximine; Thymidine; Tumor Cells, Cultured | 1993 |
Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Carcinoma; Cell Division; Cystine; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Tumor Cells, Cultured | 1994 |
Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine.
Topics: Animals; Autoradiography; Buthionine Sulfoximine; Cysteamine; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutathione; Lung Neoplasms; Melanoma, Experimental; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Phenols | 1994 |
Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Carcinoma; Cell Division; Culture Media; Enzyme Inhibitors; Glutamic Acid; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Tumor Cells, Cultured | 1995 |
Modulation by D,L-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Buthionine Sulfoximine; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Synergism; Etoposide; Female; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil | 1992 |
Combined in vitro modulation of adriamycin resistance.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Carcinoma, Small Cell; Cell Line; Cell Survival; Doxorubicin; Drug Resistance; Glutathione; Humans; Lung Neoplasms; Membrane Glycoproteins; Methionine Sulfoximine; Neoplasm Proteins; Pleural Effusion | 1991 |
Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.
Topics: Buthionine Sulfoximine; Cell Division; Cell Survival; DNA, Neoplasm; Flow Cytometry; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Microscopy, Electron; Tumor Cells, Cultured | 1991 |
The effect of doxorubicin on the glutathione content and viability of cultured human lung cancer cell lines A549 and GLC4 210.
Topics: Adenocarcinoma; Buthionine Sulfoximine; Carcinoma, Small Cell; Cell Survival; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Doxorubicin; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Tumor Cells, Cultured | 1990 |
Glutathione content and growth in A549 human lung carcinoma cells.
Topics: Antimetabolites; Buthionine Sulfoximine; Cell Division; Cell Line; Glutathione; Humans; Kinetics; Lung Neoplasms; Methionine Sulfoximine; Time Factors; Tumor Cells, Cultured | 1990 |
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
Topics: Antimetabolites; Buthionine Sulfoximine; Carcinoma; Cell Line; Cell Nucleus; Cell Survival; Cisplatin; DNA; DNA Repair; Dose-Response Relationship, Drug; Drug Resistance; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Neoplasm Proteins | 1990 |
Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.
Topics: Antineoplastic Agents; Bleomycin; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Cisplatin; Glutathione; Humans; Lung; Lung Neoplasms; Melphalan; Methionine Sulfoximine; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Zinostatin | 1986 |
Enhanced cadmium cytotoxicity in A549 cells with reduced glutathione levels is due to neither enhanced cadmium accumulation nor reduced metallothionein synthesis.
Topics: Buthionine Sulfoximine; Cadmium; Glutathione; Humans; Lung Neoplasms; Maleates; Metallothionein; Methionine Sulfoximine; Sulfur Radioisotopes; Tumor Cells, Cultured | 1989 |
Enhanced cytostatic activity of the sesquiterpene lactone eupatoriopicrin by glutathione depletion.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Buthionine Sulfoximine; Cell Line; Female; Glutathione; Lung Neoplasms; Male; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Sesquiterpenes; Tumor Cells, Cultured | 1989 |
Glutathione is involved in the early cadmium cytotoxic response in human lung carcinoma cells.
Topics: Buthionine Sulfoximine; Cadmium; Drug Interactions; Glutathione; Humans; In Vitro Techniques; Lung Neoplasms; Methionine Sulfoximine | 1988 |
Effect of cellular glutathione depletion on cadmium-induced cytotoxicity in human lung carcinoma cells.
Topics: Buthionine Sulfoximine; Cadmium; Cell Survival; Glutathione; Humans; Lung Neoplasms; Maleates; Methionine Sulfoximine; Tumor Cells, Cultured | 1987 |
Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Buthionine Sulfoximine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Cysteine; Glutathione; Lung Neoplasms; Male; Methionine Sulfoximine; Mice; Mice, Inbred C3H | 1986 |
Buthionine sulfoximine inhibition of cystine uptake and glutathione biosynthesis in human lung carcinoma cells.
Topics: Buthionine Sulfoximine; Cell Line; Cysteine; Cystine; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Sulfur Radioisotopes | 1985 |